Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
577 Results for "
IG
" in MedChemExpress (MCE) Product Catalog:
Products (577)
577 Results for "IG" in MCE Product Catalog:
Cat. No.: HY-P991208
Synonyms: human Flt3L; hFlt3L
Target:
Research Areas:
Cat. No.: HY-P990079
CAS No.: 2725062-35-9
Synonyms: BMS-986207; ONO-4686
Target:
Research Areas:
Cat. No.: HY-P990163
Target:
Research Areas:
Cat. No.: HY-P990030
CAS No.: 2581724-89-0
Synonyms: AB-308
Target:
Research Areas:
Cat. No.: HY-N6008
CAS No.: 41679-97-4
Category:
Iridoids Cornus officinalis Sieb. et Zucc. Terpenoids Other Diseases Plants Disease Research Fields Cornaceae Extract
Target:
Cat. No.: HY-P990031
CAS No.: 2649362-29-6
Synonyms: M-6223
Target:
Research Areas:
Cat. No.: HY-P99963
CAS No.: 2387417-06-1
Synonyms: HS636
Target:
Research Areas:
Cat. No.: HY-162776
Target:
Research Areas:
Succinate dehydrogenase-IN-3 (Ig) is an inhibitor of Succinate dehydrogenase (SDH). Succinate dehydrogenase-IN-3 has antifungal activity .
Cat. No.: HY-169930
CAS No.: 1613196-91-0
ATR kinase-IN-2 (Compound I-G-27) is a ATR protein kinase inhibitor with the Ki of 0.01 ~ 1 μΜ and can be used for study of cancer .
Cat. No.: HY-169931
CAS No.: 1613196-92-1
ATR kinase-IN-3 (Compound I-G-28) is a ATR protein kinase inhibitor with the Ki of 0.01 ~ 1 μΜ and can be used for study of cancer .
Cat. No.: HY-P990921
CAS No.: 2845128-03-0
Synonyms: REGN-9035
Research Areas:
Cat. No.: HY-P990935
CAS No.: 2779564-38-2
Synonyms: IMGN-151 Antibody
Target:
Research Areas:
HY-P990935 is an FOLR1-targeting half-IG G1 -κ/(scFv -κ-heavy) -h-CH2-CH3 type chimeric antibody .
Cat. No.: HY-101813R
CAS No.: 147076-36-6
Synonyms: HR325 (Standard)
Research Areas:
Laflunimus (Standard) is the analytical standard of Laflunimus. This product is intended for research and analytical applications. Laflunimus (HR325) is an immunosuppressive agent and an analogue of the Leflunomide-active metabolite A77 1726. Laflunimus is an orally active inhibitor of dihydroorotate dehydrogenase (DHODH). Laflunimus suppresses immunoglobulin (Ig) secretion, with IC50 values of 2.5 and 2 μM for IgM and IgG, respectively. Laflunimus also is a prostaglandin endoperoxide H synthase (PGHS) -1 and -2 inhibitor .
Cat. No.: HY-P990153
Target:
Research Areas:
Cat. No.: HY-111175
CAS No.: 905978-63-4
Research Areas:
IG-105 is an orally active and potent tubulin inhibitor that competitively inhibits [ 3H] colchicine binding to tubulin with an IC50 of 0.6 μM and inhibits tubulin polymerization with an IC50 of 3 μM. IG-105 inhibits microtubule polymerization by binding to the colchicine pocket of tubulin, induces G2-M phase arrest, and subsequently activates the caspase cascade through Bcl-2 inactivation and p53 upregulation, inducing apoptosis. IG-105 effectively overcomes multidrug resistance as a non-Pgp substrate. IG-105 can be used for research on leukemia, breast cancer, liver cancer, prostate cancer, lung cancer, melanoma, pancreatic cancer, and colon cancer .
Cat. No.: HY-P4510
CAS No.: 943235-75-4
Target:
Research Areas:
Cat. No.: HY-153658
CAS No.: 1613196-89-6
Research Areas:
ATR-IN-27 (Compound I-G-12) is an ATR inhibitor with a Ki value greater than 0.01 μM but less than 1 μM. ATR-IN-27 sensitizes colorectal cancer cells to Cisplatin (HY-17394) .
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
